|
|
||||||||
Journal of Lipid Research, Vol 36, 2450-2458, Copyright © 1995 by Lipid Research, Inc.
JF Miquel, AK Groen, MJ van Wijland, R del Pozo, MI Eder and C von Ritter
It is generally accepted that gallbladder mucin (GBM) plays an important
role in the pathogenesis of cholesterol gallstone (ChG) disease. However,
it remains unclear whether ChG patients have higher GBM concentrations than
controls. Discrepant findings regarding biliary mucin concentrations may be
due to methodological problems with the assays commonly used. The methods
currently used to quantitate mucin in bile have not been systematically
evaluated. To establish a reliable method for mucin quantification in bile,
we evaluated three mucin assays: the classic Pearson-PAS (periodic acid
Schiff) assay, a direct fluorometric assay, and a new PAS or fluorometric
assay with the following modifications of the Pearson assay: preincubation
of bile samples with TBS containing KSCN and sodium taurocholate and
micellation of biliary lipids during gel chromatographic fractionation
using 25 mM sodium taurocholate in the elution buffer. SDS-PAGE and
monoclonal anti-human-GBM (GBM59) were used to identify mucin. Highly
specific and reproducible mucin isolation was achieved with the modified
method. We found considerable loss of mucin during the different
purification steps in the Pearson method. The direct fluorometric assay
showed unspecific fluorometric signal with low molecular constituents of
bile. Our experiments showed that human-GBM can be accurately measured
after a simple modified chromatographic fractionation followed by a PAS or
fluorometric assay.
ARTICLES
Quantification of mucin in human gallbladder bile: a fast, specific, and reproducible method
Department of Medicine II, Ludwig-Maximilians-University Munich, Germany.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. H. Wang, N. H. Afdhal, S. J. Gendler, and D. Q-H. Wang Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation J. Lipid Res., March 1, 2004; 45(3): 438 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. SANDERS, S. C. DE SMEDT, E. VAN ROMPAEY, P. SIMOENS, F. DE BAETS, and J. DEMEESTER Cystic Fibrosis Sputum . A Barrier to the Transport of Nanospheres Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1905 - 1911. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |